Cargando…
An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides
BACKGROUND: Receptors specific for the sugar N-acetylgalactosamine (GalNAc) include the human type II, C-type lectin receptor macrophage galactose-type lectin/C-type lectin receptor family member 10A (MGL/CLEC10A/CD301) that is expressed prominently by human peripheral immature dendritic cells, dend...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905120/ https://www.ncbi.nlm.nih.gov/pubmed/29665849 http://dx.doi.org/10.1186/s40425-018-0339-5 |